Powder: -20°C for 3 years | In solvent: -80°C for 1 year
OPC-163493 is an orally active, liver-targeted mitochondrial uncoupling agent that diminishes Δψ (delta psi) and mitochondrial ROS (reactive oxygen species) production. This compound demonstrates antidiabetic properties and cardiovascular benefits, including lowering blood pressure, prolonging survival, and enhancing renal function in a rat model of stroke/hypertension [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | OPC-163493 is an orally active, liver-targeted mitochondrial uncoupling agent that diminishes Δψ (delta psi) and mitochondrial ROS (reactive oxygen species) production. This compound demonstrates antidiabetic properties and cardiovascular benefits, including lowering blood pressure, prolonging survival, and enhancing renal function in a rat model of stroke/hypertension [1]. |
分子量 | 335.31 |
分子式 | C14H8F3N5S |
CAS No. | 1644467-84-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
OPC-163493 1644467-84-4 Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species Inhibitor inhibitor inhibit